title: [Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder].
abstract: Cerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive disease. The diagnosis should be suspected in the presence of a suggestive clinical triad characterized by early-onset cataract, tendinous xanthomata and neurological symptoms and signs, notably cerebellar ataxia, mental retardation and pyramidal syndrome.The diagnosis is confirmed by demonstrating an increased blood level of cholestanol, or/and by molecular genetic analysis.In typical cases, brain MRI shows bilateral hyperintensity of the cerebellar nucleus dentatus together with cerebral atrophy and leukoencephalopathy. The treatment is based on the administration of chenodeoxycholic acid. The aim is to restore the negative feedback on the enzymatic cascade altered by mutation in the gene CYP27 which induces a 27-hydroxylase deficiency
authors.affiliation: Service de Neurologie, CHU de Liege, Belgique.
authors.forename: S
authors.initials: S
authors.lastname: Delstanche
authors.forename: T
authors.initials: T
authors.lastname: Deflandre
authors.forename: B
authors.initials: B
authors.lastname: Otto
authors.forename: L
authors.initials: L
authors.lastname: Tshibanda
authors.forename: P
authors.initials: P
authors.lastname: Simoni
authors.forename: G
authors.initials: G
authors.lastname: Moonen
mesh_terms: D006801:Humans; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D019294:Xanthomatosis, Cerebrotendinous / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics